Abstract
More than 100 mutations have been described for the breast-cancer-susceptibility geneBRCA1. The paper describes phenotypical aspects of three selected mutations located at the beginning, in the middle, and at the end of the gene. A remarkable decrease of the age of diagnosis of the mammary carcinoma is observed with increasing length of the putative gene product, combined with greater severity of the disease.
This is a preview of subscription content, log in via an institution to check access.
References
Couch FJ, Weber BL (1996) Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Hum Mutat 8: 8–18
Friedman LS et al. (1994) Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer inten families. Nature Genet 8: 399–404
Grade K, Jandrig B, Scherneck S (1996)BRCA1 mutation update and analysis. J Cancer Res Clin Oncol 122: 702–706
Hall JM, et al (1990) Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250: 1684–1689
Holt JT, et al (1996) Growth retardation and tumour inhibition byBRCA1. Nat Genet 12: 298–302
Koonin EV, Altschul SF, Bork P (1996) Functional motifs. Nat Genet 13: 266–267
Miki Y, et al (1994) A strong candidate for the breast and ovarian cancer susceptibility geneBRCA1. Science 266: 66–71
Narod SA, et al (1991) Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet 338: 82–83
Saurin AJ, et al (1996) Does this have a familiar RING? Trends Biochem Sci 21: 208–214
Simard J, et al (1994) Common origins ofBRCA1 mutations in Canadian breast and ovarian cancer families. Nature Genet 8, 392–398
Waindzoch B, et al (1996) A novel mutation in theBRCA1 gene in a German early-onset breast cancer family. Hum Mutat (in press)
Wooster R, Neuhausen SL, Manjion J (1994) Localization of a breast cancer susceptibility gene,BRCA2, to chromosome 13q12-13. Science 265: 2088–2090